Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
Clinical trial NCT04230330 · WITHDRAWN
Trial details
- NCT number
- NCT04230330
- Sponsor
- National Cancer Centre, Singapore
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-12
- Primary completion
- 2020-06-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.